Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

225 Articles

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 3, 2020 at 7:33 AM EDT

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July…

247sarah | May 8, 2020 at 2:02 PM EDT

Why an Appeals Court May Hold Key to Amarin Stock Future

Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that…

Paul Ausick | Mar 31, 2020 at 1:17 PM EDT

Court Rejects Patent Protection, Crushing Amarin Stock

Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news,…

Lee Jackson | Mar 31, 2020 at 7:05 AM EDT

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have…

Lee Jackson | Feb 11, 2020 at 7:15 AM EST

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Jon C. Ogg | Jan 21, 2020 at 10:15 AM EST

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout…

Chris Lange | Dec 30, 2019 at 9:50 AM EST

AstraZeneca’s FDA Nod Could Be Big

AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.

1 … 3 4 5 6 7 … 15

AstraZeneca : AZN

All AstraZeneca Articles

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Why an Appeals Court May Hold Key to Amarin Stock Future

Court Rejects Patent Protection, Crushing Amarin Stock

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

AstraZeneca’s FDA Nod Could Be Big

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

AstraZeneca : AZN

All AstraZeneca Articles

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Why an Appeals Court May Hold Key to Amarin Stock Future

Court Rejects Patent Protection, Crushing Amarin Stock

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

AstraZeneca’s FDA Nod Could Be Big

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income